Multiple muscle wasting-related transcription factors are acetylated in dexamethasone-treated muscle cells

Wei Chamberlain1, Patricia Gonnella, Nima Alamdari

  • 1Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.

Insights

Acetylation of muscle-wasting transcription factors increases during muscle atrophy. The histone acetyltransferase p300 regulates this acetylation, impacting muscle loss and suggesting new therapeutic targets.

Area of Science:

  • Muscle physiology
  • Molecular biology
  • Biochemistry

Background:

  • Histone acetyltransferase p300 activity is elevated in muscle wasting.
  • Posttranslational modifications, like acetylation, affect transcription factor function.
  • The acetylation status of muscle mass regulators in atrophy is unknown.

Purpose of the Study:

  • To investigate the acetylation of key transcription factors in muscle wasting.
  • To determine the role of p300 in transcription factor acetylation and muscle atrophy.

Main Methods:

  • Dexamethasone treatment of L6 myotubes to model muscle wasting.
  • Quantification of acetylated transcription factors (C/EBPβ, C/EBPδ, FOXO1, FOXO3a, NF-kB/p65).
  • p300 siRNA to assess p300's role in acetylation and atrophy.

Main Results:

  • Dexamethasone increased acetylation of C/EBPβ, C/EBPδ, FOXO1, FOXO3a, and p65.
  • p300 downregulation reduced transcription factor acetylation.
  • Reduced p300 also decreased dexamethasone-induced myotube atrophy and MuRF1 expression.

Conclusions:

  • Muscle wasting involves acetylation of transcription factors like C/EBP, FOXO, and NF-kB.
  • p300-mediated acetylation plays a role in glucocorticoid-induced muscle atrophy.
  • Targeting acetylation pathways may offer strategies to combat muscle wasting.

Related Concept Videos

Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Histone Modification02:32

Histone Modification

The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
General Transcription Factors01:30

General Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...